Stocks
Allogene Therapeutics (ALLO) FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -206.3 | -225.7 | -239.2 | -201.0 | -149.6 | -109.5 | ||
| Changes by years, y/y, % | +14% | +9% | +6% | -16% | -26% | -3.7% | |||
Allogene Therapeutics. FCF, bln rub
Allogene Therapeutics. FCF, changes, %
Allogene Therapeutics. FCF, sum by quarters, bln rub
Allogene Therapeutics (ALLO) FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| FCF, bln rub | ? | -53.0 | -39.1 | -29.9 | -27.6 | -12.9 | -109.5 | |
| Changes by years, y/y, % | -5% | -39% | -33% | -25% | -76% | |||
| Changes by quarters, q/q, % | +43% | -26% | -23% | -8% | -53% | |||
